Medical Congress News
Medical Digest & Congress Report
The MedicalDigest.org / CongressReport.eu podcast covers the latest evidence based medical news from cardiology, hematology, oncology, diabetology, pulmonology, dermatology, urology and more. Made for healthcare professionals and researchers, we are an independent, open-access platform. CongressReport.eu portal enables HCPs to get acquainted with new clinical trial results, medical diagnostic and treatment guidelines. Our non-promotional website collects and stores the relevant scientific information, KOL insights, key lectures, poster presentations in a user-friendly format.
Author
Medical Congress News
Category
Podcast website
Latest episode
Jun 15, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
DASH-Patterned Groceries Reduce Blood Pressure - report from AHA 2025 03.12.2025 10:03
Professor Stephen P. Juraschek discusses the results from the GoFresh randomized clinical trial presented at at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:dash-patterned-groceries-reduce-blood-pressure
TUXEDO-2: Ticagrelor vs. Prasugrel in Patients With Diabetes and Multivessel Disease After PCI - report from AHA 2025 03.12.2025 6:36
Professor Sripal Bangalore discusses the findings from the TUXEDO-2 trial presented at at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:tuxedo-2-ticagrelor-vs-prasugrel-patients-diabetes-and-multivessel-disease-after-pci
Aldosterone and Mineralocorticoid Receptors: New Paradigms and Novel Therapies - report from AHA 2025 03.12.2025 9:04
Professor John M. Flack shares his insights on the new paradigms and novel therapies in aldosterone and mineralocorticoid receptors at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:aldosterone-and-mineralocorticoid-receptors-new-paradigms-and-novel-therapies
Navigating AHA Scientific Statements: Advancing Evidence-Based Cardiovascular Care - report from AHA 2025 03.12.2025 9:50
Professor Bradley S. Marino shares his insights on the advancing evidence-based cardiovascular care at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:navigating-aha-scientific-statements-advancing-evidence-based-cardiovascular-care
A Randomized Clinical Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Acute Coronary Syndrome Patients: The TARGET-D Trial - report from AHA 2025 02.12.2025 5:57
Professor Heidi T. May explains heart attack risk halved in adults with heart disease taking tailored vitamin D doses at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:randomized-clinical-trial-evaluating-vitamin-d-normalization-major-adverse-cardiovascular-related-events-among-acute-coronary-syndrome-patients-target-d-trial
First-in-human trial of CRISPR gene-editing therapy safely lowered cholesterol, triglycerides - report from AHA 2025 02.12.2025 5:18
Professor Stephen Nicholls shares his insights on the first-in-human trial of CRISPR gene-editing therapy at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:first-human-trial-crispr-gene-editing-therapy-safely-lowered-cholesterol-triglycerides
Once-weekly Tirzepatide versus Dulaglutide for Heart Failure Outcomes in Patients with Type 2 Diabetes, ASCVD, and History of Heart Failure - report from AHA 2025 02.12.2025 6:52
Professor Stephen Nicholls shares his insights on the pre-specified analysis of the SURPASS-CVOT Randomized Clinical Trial at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:once-weekly-tirzepatide-versus-dulaglutide-heart-failure-outcomes-patients-type-2-diabetes-ascvd-and-history-heart-failure
Impact of Cardiovascular-Focused Messaging to Improve Influenza Vaccination on Cardiovascular-Kidney-Metabolic Care Patterns and Clinical Outcomes: Insights from the KP VACCINATE Megatrial 02.12.2025 4:44
Professor Ankeet Bhatt shares his insights from the KP VACCINATE Megatrial presented at at AHA Scientific Sessions 2025. Videó: https://medicaldigest.org/scientific-contents/interview:impact-cardiovascular-focused-messaging-improve-influenza-vaccination-cardiovascular-kidney-metabolic-care-patterns-and-clinical-outcomes-insights-kp-vaccinate-megatrial
Resistance Exercise Therapy After COVID-19 Infection: a Randomized, Controlled Trial - report from AHA 2025 02.12.2025 5:57
Professor Stuart Gray shares his insights on the resistance exercise therapy after COVID-19 infection at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:resistance-exercise-therapy-after-covid-19-infection-randomized-controlled-trial
Metformin as an Adjunctive Therapy to Catheter Ablation of Atrial Fibrillation - report from AHA 2025 02.12.2025 1:28
Professor Amrish Deshmukh shares his insights on metformin as an adjunctive therapy to catheter ablation of atrial fibrillation at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:metformin-adjunctive-therapy-catheter-ablation-atrial-fibrillation
Highlights of AHA / ACC Blood Pressure Management Guideline 02.12.2025 2:58
Professor Daniel Jones shares his insights on the AHA / ACC Blood Pressure Management Guideline at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:highlights-aha-acc-blood-pressure-management-guideline
POLY-HF: Daily Polypill Boosts Heart Function, QOL, and Cuts Hospitalizations in Underserved Patients With HFrEF - report from AHA 2025 01.12.2025 4:17
Professor Ambarish Pandey presented the data of POLY-HF trial at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:poly-hf-daily-polypill-boosts-heart-function-qol-and-cuts-hospitalizations-underserved-patients-hfref
SOTA-P-CARDIA Trial: A Randomized Trial of Sotagliflozin in HFpEF patients without diabetes - report from AHA 2025 01.12.2025 9:00
Professor Juan J. Badimon discusses the SOTA-P-CARDIA Trial, a randomized trial of sotagliflozin in HFpEF patients without diabetes, presented at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:sota-p-cardia-trial-randomized-trial-sotagliflozin-hfpef-patients-without-diabetes
The Clinicians view on the 2025 Guideline for Acute Coronary Syndromes - report from AHA 2025 01.12.2025 5:38
Professor Matthew Tomey discusses the clinicians view on the2025 Guideline for Acute Coronary Syndromes at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:clinicians-view-2025-guideline-acute-coronary-syndromes
The New 2025 Guideline for Acute Coronary Syndromes: The European perspective - report from AHA 2025 01.12.2025 5:37
Professor Tiziana Claudia Aranzulla shares her insights on the Guideline for Acute Coronary Syndromes from the European perspective at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:new-2025-guideline-acute-coronary-syndromes-european-perspective
State of the art tumor-targeting IL-12 immunocytokine therapies - report from SITC 2025 27.11.2025 7:13
Dr. Gregory Conn shares his insights on state of the art tumor-targeting IL-12 immunocytokine therapies after SITC's 40th Anniversary Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:state-art-tumor-targeting-il-12-immunocytokine-therapies
Reprogramming the Immune Microenvironment to Intercept Lung Adenocarcinoma Precancer - report from SITC 2025 27.11.2025 3:46
Professor Jianjun Zhang shares his insights on reprogramming the immune microenvironment to intercept lung adenocarcinoma precancer at SITC's 40th Anniversary Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:reprogramming-immune-microenvironment-intercept-lung-adenocarcinoma-precancer
Primary analysis of patients with high-risk localized, locally recurrent, or regionally advanced cutaneous squamous cell carcinoma treated with neoadjuvant PD-1 therapy - report from SITC 2025 27.11.2025 5:09
Professor Gino In presented data from the NeoPOWER trial, to study the role of neoadjuvant PD-1 alone in CSCC at SITC's 40th Anniversary Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:primary-analysis-patients-high-risk-localized-locally-recurrent-or-regionally-advanced-cutaneous-squamous-cell-carcinoma-treated-neoadjuvant-pd-1-therapy
Phase I Trial of DOC1021 Cell-Based Immunotherapy for Resectable or Borderline Resectable Pancreatic Ductal Adenocarcinoma - report from SITC 2025 27.11.2025 8:04
Professor William Decker discusses the Phase I Trial of DOC1021 cell-based immunotherapy for resectable or borderline resectable pancreatic ductal adenocarcinoma at SITC's 40th Anniversary Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:phase-i-trial-doc1021-cell-based-immunotherapy-resectable-or-borderline-resectable-pancreatic-ductal-adenocarcinoma
How to optimize PD1/PDL1 treatment? - report from SITC 2025 27.11.2025 8:24
Professor Gordon J. Freeman shares his insights on how to optimize PD1/PDL1 treatment at SITC's 40th Anniversary Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:how-optimize-pd1pdl1-treatment
Modulating the Tumor Microenvironment with T Cell Bispecifics - report from SITC 2025 27.11.2025 4:36
Professor Sumit K. Subudhi shares his insights on modulating the tumor microenvironment with T Cell bispecifics at SITC's 40th Anniversary Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:modulating-tumor-microenvironment-t-cell-bispecifics
Comparative Cardioprotective Effects of GLP-1 Receptor Agonists versus SGLT2 Inhibitors in Pulmonary Arterial Hypertension: Insights from a Large-Scale Real-World data analysis 27.11.2025 7:03
Dr. Saud Alawad and Prof. Sunil Sharma discuss the comparative cardioprotective effects of GLP-1 receptor agonists versus SGLT2 inhibitors in pulmonary arterial hypertension after the American College of Chest Physicians (CHEST) 2025 Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:comparative-cardioprotective-effects-glp-1-receptor-agonists-versus-sglt2-inhibitors-pu...
Ensifentrine treatment improves COPD symptoms and quality of life in a pooled analysis of the ENHANCE trials - report from CHEST 2025 27.11.2025 7:12
Professor Nicola Hanania discuss the lessons from the ENHANCE trials were presented at the American College of Chest Physicians (CHEST) 2025 Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:ensifentrine-treatment-improves-copd-symptoms-and-quality-life-pooled-analysis-enhance-trials
Sleep Apnea Significantly Impacts Mortality Benefit of GLP-1s - report from CHEST 2025 27.11.2025 13:27
Dr. Cosmo Fowler explains thet data revealed one-year mortality in patients with type 2 diabetes prescribed GLP-1 RAs was substantially lower than those not prescribed the drugs, and disproportionate benefit for those also diagnosed with OSA. The results were presented at the American College of Chest Physicians (CHEST) 2025 Annual Meeting. Video: https://medicaldigest.org/scientific-contents/inte...
Advances in the Development of Therapeutic Targets in the Platelet for Prevention of Thrombosis - report from AHA 2025 26.11.2025 8:36
Professor Paola Patrignani shares her insights on the advances in the development of therapeutic targets in the platelet for prevention of thrombosis at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:advances-development-therapeutic-targets-platelet-prevention-thrombosis
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.